Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Application of a glyceride-mimetic prodrug strategy to deliver protease inhibitors to gut lymph to alleviate organ failure.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Predicting clinical efficacy of lung gene delivery in people with cystic fibrosis: which <i>in vitro</i> and <i>in vivo</i> models best predict outcomes in human lungs?

Expert opinion on drug delivery·2026
Same author

The expanding role of formulations to enable oral delivery of poorly water-soluble drugs.

Nature reviews. Drug discovery·2026
Same author

An oral allopregnanolone prodrug bypasses liver metabolism via lymphatic transport enabling bioavailability in animals and humans.

Science translational medicine·2026
Same author

Inhalable gene and RNA therapy for cystic fibrosis: perspectives and progress in clinical development.

Nanomedicine (London, England)·2026
Same author

Dysfunctional adipose tissue-lymphatic crosstalk in obesity.

Nature reviews. Endocrinology·2026

Related Experiment Video

Updated: May 31, 2026

Intra-lymph Node Injection of Biodegradable Polymer Particles
09:06

Intra-lymph Node Injection of Biodegradable Polymer Particles

Published on: January 2, 2014

Targeting the lymphatics using dendritic polymers (dendrimers).

Lisa M Kaminskas1, Christopher J H Porter

  • 1Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC, 3052, Australia.

Advanced Drug Delivery Reviews
|June 21, 2011
PubMed
Summary
This summary is machine-generated.

Dendrimers, or branched polymers, show promise for drug delivery and imaging. Larger, hydrophilic dendrimers preferentially drain into the lymphatic system, enhancing targeting potential for disease treatment.

More Related Videos

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
10:35

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Published on: February 5, 2021

Dendrimer-based Uneven Nanopatterns to Locally Control Surface Adhesiveness: A Method to Direct Chondrogenic Differentiation
14:46

Dendrimer-based Uneven Nanopatterns to Locally Control Surface Adhesiveness: A Method to Direct Chondrogenic Differentiation

Published on: January 20, 2018

Related Experiment Videos

Last Updated: May 31, 2026

Intra-lymph Node Injection of Biodegradable Polymer Particles
09:06

Intra-lymph Node Injection of Biodegradable Polymer Particles

Published on: January 2, 2014

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
10:35

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Published on: February 5, 2021

Dendrimer-based Uneven Nanopatterns to Locally Control Surface Adhesiveness: A Method to Direct Chondrogenic Differentiation
14:46

Dendrimer-based Uneven Nanopatterns to Locally Control Surface Adhesiveness: A Method to Direct Chondrogenic Differentiation

Published on: January 20, 2018

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Polymer Chemistry

Background:

  • Dendrimers are synthetic macromolecules with a branched, tree-like structure.
  • Their polyfunctional surface allows for the attachment of drugs and pharmacokinetic modifiers like polyethylene glycol (PEG).
  • These characteristics drive interest in dendrimers for diverse biomedical applications.

Purpose of the Study:

  • To explore the lymphatic targeting potential of dendrimers.
  • To investigate how dendrimer size, hydrophilicity, and charge influence lymphatic uptake and retention.
  • To assess dendrimers as agents for lymphatic imaging and drug delivery.

Main Methods:

  • Subcutaneous administration of dendrimers of varying sizes and properties.
  • Analysis of preferential drainage into peripheral lymphatic capillaries.
  • Evaluation of factors influencing lymph node uptake, including size, hydrophilicity, and surface charge.
  • Assessment of extravasation from systemic circulation and lymphatic recirculation.

Main Results:

  • Larger dendrimers (> 8 nm) preferentially drain into lymphatic capillaries after subcutaneous injection.
  • Increasing hydrophilicity and reducing surface charge enhance lymphatic drainage but reduce lymph node retention.
  • Size, hydrophilicity, and charge significantly impact dendrimer behavior within the lymphatic system.
  • Larger hydrophilic dendrimers can extravasate, enter the lymphatic system, and recirculate into the blood.

Conclusions:

  • Dendrimers possess significant potential as lymphatic imaging agents and drug delivery vectors.
  • Dendrimer size and surface properties are critical determinants of their lymphatic pharmacokinetics.
  • Lymphatic recirculation is a potential characteristic of PEGylated dendrimers, suggesting prolonged systemic circulation times.